Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
| (2R,3R)-1-[4-[(2-Chloro-4-fluorophenyl)methoxy]phenyl]sulfonyl-N,3-dihydroxy-3-methylpiperidine-2-carboxamide | IC50 | 1.0 [1], 6.3 [2], 18.0 [3] | |
| (2R)-N-[[(4R)-4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl]methyl]-2-[[4-(trifluoromethyl)phenyl]methyl]butanamide | IC50 | 2.0 [1], 20.0 [2] | |
| N-[[(4R)-4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl]methyl]-2,2-dimethyl-3-[4-(trifluoromethyl)phenyl]propanamide | IC50 | 4.0 [1], 64.0 [2] | |
| (2S)-2-Cyclopropyl-N-[[(4R)-4-cyclopropyl-2,5-dioxoimidazolidin-4-yl]methyl]-3-[4-(trifluoromethyl)phenyl]propanamide | IC50 | 2.0 [1], 18.0 [2] | |
| (2S)-N-[[(4R)-4-Cyclopropyl-2,5-dioxoimidazolidin-4-yl]methyl]-3-methyl-2-[[4-(trifluoromethyl)phenyl]methyl]butanamide | IC50 | 8.0 [1], 150.0 [2] | |
MLA | "Quest Database™ ADAMTS5 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 15 Dec. 2025, https://www.aatbio.com/data-sets/adamts5-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 15). Quest Database™ ADAMTS5 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/adamts5-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |